Short interfering RNAs (siRNAs) for reducing dopaminergic phenotypic markers

Journal of Neuroscience Methods

Volumn 131, Issue 1-2, 2003, Pages 51-56

  Bäckman, Cristina ^a   Zhang, YaJun ^a   Hoffer, Barry J ^a   Tomac, Andreas C ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

cRet; Dopamine; Midbrain; Nurr1; RNA interference; RNAi; Short interfering RNA; siRNA; Tyrosine hydroxylase

Indexed keywords

COMPLEMENTARY DNA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LUCIFERASE; RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NR4A2; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EMBRYO; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MESENCEPHALON; PHENOTYPE; PLASMID; PRIORITY JOURNAL;

EID: 0344945426     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(03)00236-X     Document Type: Article

References (24)

1. Bäckman C., Perlmann T., Wallen A., Hoffer B.J., Morales M. A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res. 18:1999;125-132.
2. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 409(6818):2001;363-366.
3. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296(5567):2002;550-553.
4. Caplen N.J., Parrish S., Imani F., Fire A., Morgan R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. 98(17):2001;9742-9747.
5. Castillo S.O., Baffi J., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., et al. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell. Neurosci. 11:1998;36-46.
6. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20(23):2001;6877-6888.
7. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391(6669):1998;806-811.
8. Grishok A., Pasquinelli A.E., Conte D., Li N., Parrish S., Ha I., et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell. 106(1):2001;23-34.
9. Hamilton A.J., Baulcombe D.C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science. 286(5441):1999;950-952.
10. Hammond S.M., Boettcher S., Caudy A.A., Kobayashi R., Hannon G.J. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science. 293(5532):2001;1146-1150.
11. Hoffer B.J., Hoffman A., Bowencamp K., Huettl P., Hudson J., Martin D., et al. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neuroscience Lett. 182:1994;107-111.
12. Holen T., Amarzguioui M., Wiiger M.T., Babaie E., Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30(8):2002;1757-1766.
13. Jarvis RA, Ford LP. The siRNA target site is an important parameter for inducing RNAi in human cells. 2002. www.ambion.com/techlib/tn/85/852.html .
14. Lin L.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
15. Montgomery M.K., Xu S., Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 95(26):1998;15502-15507.
16. Nykanen A., Haley B., Zamore P.D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell. 107(3):2001;309-321.
17. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16(8):2002;948-958.
18. Paul C.P., Good P.D., Winer I., Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20(5):2002;505-508.
19. Pichel J.G., Shen L., Sheng H.Z., Granholm A.C., Drago J., Grinberg A., et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 382(6586):1996;73-76.
20. Tuschl T. The siRNA user guide. 2001. www.mpibpc.gwdg.de/abteilungen/100/ 105/sirna.html .
21. Tuschl T., Zamore P.D., Lehmann R., Bartel D.P., Sharp P.A. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13(24):1999;3191-3197.
22. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 101(1):2000;25-33.
23. Zetterström R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1 deficient mice. Science. 276:1997;248-250.
24. Zhou Q.Y., Quaife C.J., Palmiter R.D. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature. 374(6523):1995;640-643.